We offer FREE SHIPPPING on all orders!
We offer FREE SHIPPPING on all orders!
| THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for invitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic. |
Trenbolone Acetate 100 is an injectable preparation commonly formulated to contain 100 mg of trenbolone acetate per milliliter. Trenbolone is a synthetic anabolic-androgenic steroid derived from the 19-nortestosterone family. The acetate ester gives it a relatively short duration of action compared with longer trenbolone esters.
Unlike testosterone, trenbolone is not approved for human therapeutic use in the United States. Trenbolone acetate has instead been used in veterinary medicine, particularly in livestock. Products marketed for human bodybuilding use therefore should not be treated as equivalent to an approved human pharmaceutical.
Trenbolone acetate consists of the active steroid trenbolone attached to an acetate ester.
The acetate ester primarily controls the compound's release. After administration, esterases remove the acetate group and release trenbolone, which can interact strongly with androgen receptors.
Trenbolone was structurally engineered to have substantial anabolic and androgenic activity while resisting several metabolic pathways that affect testosterone.
A concentration of:
Trenbolone Acetate: 100 mg/mL
means that one milliliter contains 100 mg of the esterified compound.
The entire 100 mg is not trenbolone because the acetate ester contributes some molecular weight.
Trenbolone acetate is approximately 87% trenbolone by molecular weight, meaning 100 mg of trenbolone acetate represents roughly 87 mg of trenbolone after accounting for the ester.
This figure describes molecular composition rather than an appropriate human dose.
Trenbolone has a high affinity for the androgen receptor.
Once trenbolone reaches androgen-responsive tissues, receptor activation changes gene transcription and produces substantial anabolic and androgenic activity.
This can influence skeletal muscle protein metabolism, nitrogen retention, body composition, and other androgen-dependent processes.
Its strong anabolic properties are the primary reason trenbolone has become known in bodybuilding despite the absence of an approved human medical indication.
Trenbolone can produce substantial anabolic activity in skeletal muscle. Its pharmacology supports increased nitrogen retention and protein synthesis, creating conditions favorable to maintaining or increasing lean tissue.
This does not mean that the magnitude of an anabolic effect is a measure of safety. Trenbolone's strong androgen-receptor activity and lack of an established therapeutic human dosing framework make the risk profile particularly important.
Claims assigning precise anabolic-to-androgenic numerical ratios to trenbolone are also often repeated online as though they directly predict real-world effects. Those ratios originate from experimental models and should not be interpreted as a reliable human side-effect scale.
Trenbolone and testosterone are fundamentally different compounds.
Testosterone is an endogenous human hormone with established medical applications. Trenbolone is a synthetic 19-nor anabolic steroid and is not an approved testosterone-replacement drug.
Testosterone can be directly aromatized into estradiol. Trenbolone itself is generally regarded as non-aromatizing, meaning aromatase does not convert it into estrogen in the same manner as testosterone.
That does not make trenbolone free of endocrine effects.
Trenbolone does not directly aromatize into estradiol.
However, trenbolone and other 19-nor steroids can interact with progesterone receptors, adding complexity to their endocrine effects.
Consequently, breast symptoms or other hormonal problems occurring during multi-drug anabolic-steroid use cannot reliably be diagnosed simply by assuming that "high estrogen" is responsible.
Using additional medications to manipulate estrogen or prolactin without laboratory and medical evaluation can introduce further risks.
Despite not being testosterone, trenbolone has powerful androgenic activity.
Potential androgen-related effects include:
Androgenic effects vary substantially according to genetics and overall exposure.
Trenbolone can strongly suppress the hypothalamic-pituitary-gonadal axis.
Negative feedback reduces signaling from the hypothalamus and pituitary, resulting in decreased LH and FSH.
This can significantly suppress endogenous testosterone production.
Possible consequences include low endogenous testosterone, impaired testicular function, decreased testicular volume, reduced sperm production, and infertility.
The fact that trenbolone itself has androgenic activity does not prevent this suppression.
Suppression of LH and FSH can interfere substantially with spermatogenesis.
Fertility may therefore decline during exposure, potentially producing very low sperm counts or azoospermia.
Recovery after discontinuation can vary considerably between individuals, particularly after prolonged or repeated anabolic-steroid exposure. Anyone concerned about future fertility should discuss this with a reproductive or endocrine specialist rather than assuming recovery will occur on a particular timeline.
Cardiovascular effects are among the major concerns surrounding nonmedical anabolic-androgenic steroid use.
Potential problems associated with substantial AAS exposure can include:
Risk is influenced by total exposure, duration, concurrent drugs, genetics, age, blood pressure, smoking, cholesterol, and underlying cardiovascular health.
The absence of estrogen conversion does not make trenbolone cardiovascularly benign.
Trenbolone is sometimes described online as inherently "kidney toxic," but interpreting renal markers in highly muscular people using anabolic steroids can be complicated. Creatinine can be influenced by muscle mass, training, hydration, diet, and supplements.
That does not mean abnormal kidney markers should be ignored.
Persistent abnormalities in kidney function, urine protein, blood pressure, or other renal indicators warrant medical evaluation.
Trenbolone is not a 17-alpha-alkylated oral steroid, so its hepatic profile differs from compounds specifically modified to survive oral metabolism. Nevertheless, anabolic-steroid use can still affect liver-related laboratory markers, and abnormal results require appropriate evaluation.
Users of trenbolone have reported sleep disruption, night sweats, anxiety, irritability, mood changes, and reduced exercise tolerance.
The frequency and magnitude of these effects are difficult to quantify because controlled human safety data are limited and illicit-market products introduce additional uncertainty.
Severe anxiety, major mood changes, persistent insomnia, aggression, depression, or other significant psychiatric symptoms warrant medical attention.
Night sweating is frequently reported anecdotally in association with trenbolone.
The precise mechanism has not been established adequately in controlled human research.
Because sweating can also occur with infections, endocrine disorders, medications, and other illnesses, persistent or severe night sweats should not automatically be attributed to trenbolone.
A sudden coughing episode immediately after injection is widely referred to in bodybuilding communities as "tren cough."
Reported episodes can involve coughing, chest tightness, shortness of breath, flushing, or an unusual taste or sensation shortly after an injection.
The exact mechanism has not been definitively established. Similar acute reactions can occur with injections of other oil-based steroid preparations.
Significant breathing difficulty, persistent chest pain, fainting, blue discoloration, or severe symptoms require urgent medical evaluation rather than assuming the episode is a harmless expected effect.
As with other injectable preparations, potential complications include pain, swelling, inflammation, bleeding, abscess formation, infection, and reactions to carrier oils or solvents.
An additional concern with unregulated products is uncertainty about sterility, concentration, contaminants, and whether the vial actually contains the compound stated on its label.
Progressively worsening redness, warmth, swelling, severe pain, drainage, or fever after an injection warrants medical evaluation.
Potential or reported concerns associated with trenbolone/AAS exposure include acne, oily skin, accelerated androgenic hair loss, suppression of endogenous testosterone, impaired fertility, unfavorable cholesterol changes, increased blood pressure, cardiovascular strain, sleep disturbance, night sweats, mood changes, sexual-function changes, and injection-related complications.
Because trenbolone has not gone through the human approval process used to establish a therapeutic indication, standardized human dosing, and a conventional prescribing safety profile, there is considerably less controlled clinical information than exists for medications such as testosterone cypionate or enanthate.
The acetate ester is relatively short.
Longer esterified forms release trenbolone more gradually, while acetate produces a faster concentration-time profile.
Once the ester has been removed, however, the active steroid is trenbolone. The ester primarily changes the pharmacokinetics rather than transforming trenbolone into a different anabolic steroid.
Compound: Trenbolone Acetate
Common Concentration: 100 mg/mL
Drug Class: Anabolic-androgenic steroid
Active Steroid: Trenbolone
Ester: Acetate
Release Profile: Relatively short acting
Approximate Trenbolone Content: About 87 mg trenbolone per 100 mg trenbolone acetate
Anabolic Activity: High
Androgenic Activity: High
Direct Aromatization to Estradiol: No
Progestogenic Activity: Present
Suppresses Natural Testosterone: Yes
Can Impair Fertility: Yes
Approved Human Medical Use in the U.S.: No
Historical/Current Legitimate Application: Veterinary/livestock use
Trenbolone acetate is a potent synthetic anabolic-androgenic steroid with a relatively short acetate ester. Its strong androgen-receptor activity accounts for its reputation for pronounced effects on muscle and body composition, but those properties also come with substantial endocrine and cardiovascular concerns.
It differs importantly from testosterone products because trenbolone is not simply another testosterone ester. Testosterone cypionate, enanthate, propionate, and suspension ultimately deliver the natural hormone testosterone; trenbolone acetate delivers a different synthetic steroid altogether.
The lack of an approved human therapeutic indication also means there is no medically established bodybuilding dose or cycle that can be characterized as safe, and human safety information is considerably more limited than it is for approved testosterone medications.
We do not accept returns or issue refunds for any reason, beside manufacturing defects.
Feel free to contact us if you have any questions or concerns about our Return Policy.
